Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women

Depression and Anxiety

Volumn 30, Issue 12, 2013, Pages 1161-1169

  Wolf, Erika J ^a,b   Mitchell, Karen S ^a,b   Logue, Mark W ^b,c   Baldwin, Clinton T ^b   Reardon, Annemarie F ^a   Humphries, Donald E ^a,b   Miller, Mark W ^a,b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

latent variable; PTSD; rs2284218; rs8192496; single nucleotide polymorphisms; veterans; women

Indexed keywords

ADULT; AGED; ARTICLE; CORTICOTROPIN RELEASING HORMONE RECEPTOR 2 GENE; DISEASE SEVERITY; DSM-IV; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INJURY; INTRON; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED INTERVIEW;

LATENT VARIABLE; PTSD; RS2284218; RS8192496; SINGLE NUCLEOTIDE POLYMORPHISMS; VETERANS; WOMEN;

ADULT; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPOUSES; STRESS DISORDERS, POST-TRAUMATIC; VETERANS; YOUNG ADULT;

EID: 84889888317     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22176     Document Type: Article

References (61)

1. Lavicky J, Dunn AJ,. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 1993; 60: 602-612. (Pubitemid 23030957)
2. Price ML, Lucki I,. Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor. J Neurosci 2001; 21: 2833-2841. (Pubitemid 32298224)
3. Valentino RJ, Commons KG,. Peptides that fine-tune the serotonin system. Neuropeptides 2005; 39: 1-8. (Pubitemid 41373322)
4. Kovács, K. J., CRH: the link between hormonal-, metabolic- and behavioral responses to stress. J Chem Neuroanat, in press.
5. Heinrichs SC, Koob GF,. Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J Pharmacol Exp Ther 2004; 311: 427-440. (Pubitemid 39391526)
6. Bale TL, Vale WW,. CFR and CFR receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 2004; 44: 525-557. (Pubitemid 38263852)
7. Flandreau EI, Ressler KJ, Owens MJ, et al. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology 2012; 37: 27-38.
8. van Gaalen MM, Stenzel-Poore MP, Holsboer F, et al. Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci 2002; 15: 2007-2015. (Pubitemid 35471889)
9. Holsboer F,. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 1999; 33: 181-214. (Pubitemid 29178663)
10. Lloyd RB, Nemeroff CB,. The role of corticotropin-releasing hormone in the pathophysiology of depression: therapeutic implications. Curr Top Med Chem 2011; 11: 609-617.
11. Nemeroff CB,. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry 1988; 21: 76-82.
12. Ströhle A, Holsboer F,. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 2003; 36: S207-S214. (Pubitemid 38085139)
13. Baker DG, West SA, Nicholson WE, et al. Serial CSF corticotropin- releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1999; 156: 585-588. (Pubitemid 29162980)
14. Sautter FJ, Bissette G, Wiley J, et al. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry 2003; 54: 1382-1388. (Pubitemid 37522162)
15. Yehuda R,. Biology of posttraumatic stress disorder. J Clin Psychiatry 2001; 62 (Suppl 17): 41-46. (Pubitemid 32720665)
16. Arborelius L, Owens MJ, Plotsky PM, et al. The role of corticotrophin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1-12. (Pubitemid 29044562)
17. Chalmers DT, Lovenberg TW, De Souza EB,. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995; 15: 6340-6350.
18. Lebow M, Neufeld-Cohen A, Kuperman Y, et al. Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis. J Neurosci 2012; 32: 6906-6916.
19. van Pett K, Viau V, Bittencourt JC, et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000; 428: 191-212.
20. Ishitobi Y, Nakayama S, Yamaguchi K, et al. Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population. Am J Med Genet 2012; 159: 429-436.
21. Bale TL,. Sensitivity to stress: dysregulation in CRF pathways and disease development. Horm Behav 2005; 48: 1-10. (Pubitemid 40779285)
22. Bale TL, Contarino A, Smith GW, et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress. Nat Genet 2000; 25: 410-414. (Pubitemid 30187443)
23. Coste SC, Kesterson RA, Heldwein KA, et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotrophin- releasing hormone receptor-2. Nat Genet 2000; 24: 403-409. (Pubitemid 30187442)
24. Kishimoto T, Radulovic J, Radulovic M, et al. Deletion of CRHR2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24: 415-419. (Pubitemid 30187444)
25. Valdez GR, Zorrilla EP, Rivier J, et al. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res 2003; 8: 206-212. (Pubitemid 36829440)
26. Neufeld-Cohen A, Kelly PAT, Paul ED, et al. Chronic activation of corticotrophin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge. Biol Psychiatry 2012; 72: 437-447.
27. de, Luca V, Tharmalingam S, Kennedy JL,. Association study between the corticotrophin-releasing hormone receptor 2 gene and suicidality in bipolar disorder. Eur. Psychiatry 2007; 22: 282-287. (Pubitemid 47088197)
28. Papiol S, Arias B, Gastrõ C, et al. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment. J Affect Disord 2007; 104: 83-90. (Pubitemid 350052308)
29. Wong M-L, Dong C, Maestre-Mesa J, et al. Polymorphisms in inflammation-related genes are association with susceptibility to major depression and antidepressant response. Mol Psychiatry 2008; 13: 800-812.
30. Villafuerte SM, Del-Favero J, Adolfsson R, et al. Gene-based SNP genetic association study of corticotropin-releasing hormone receptor-2 (CRHR2) in major depression. Am J Med Genet 2002; 114: 222-226. (Pubitemid 34160475)
31. Roy A, Gorodetsky E, Yuan Q, et al. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010; 35: 1674-1683.
32. Keck ME, Kern N, Erhardt A, et al. Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet 2008; 147: 1196-1204.
33. Tharmalingam S, King N, de Luca V, et al. Lack of association between the corticotrophin-releasing hormone receptor 2 gene and panic disorder. Psychiatr Genet 2006; 16: 93-97. (Pubitemid 44502770)
34. Kas MJH, Gelegen C, van Nieuwerburgh F, et al. Compulsivity in mouse strains homologous with chromosomes 7p and 15q linked to obsessive-compulsive disorder. Am J Med Genet 2010; 153: 252-259.
35. Vázquez DM, Eskandari R, Phelka A, et al. Impact of maternal deprivation on brain corticotropin-releasing hormone circuits: prevention of CRH receptor-2 mRNA changes by desipramine treatment. Neuropsychopharmacology 2003; 28: 898-909.
36. Zohar I, Weinstock M,. Differential effect of prenatal stress on the expression of corticotropin-releasing hormone and its receptors of the hypothalamus and amygdala in male and female rats. J Neuroendocrinol 2011; 23: 320-328.
37. Bradley RG, Binder EB, Epstein MP, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65: 190-200. (Pubitemid 351214318)
38. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC, 1994.
39. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB,. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52: 1048-1060.
40. Breslau N, Peterson EL, Poisson LM, Schultz LR, Lucia VC,. Estimating post-traumatic stress disorder in the community: lifetime perspective and the impact of typical traumatic events. Psychol Med 2004; 24: 889-898. (Pubitemid 39089527)
41. True WJ, Rice J, Eisen SA, et al. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 1993; 50: 257-264. (Pubitemid 23115368)
42. Stein MB, Jang KJ, Taylor S, Vernon PA, Livesley WJ,. Genetic and environmental influences on trauma exposure and posttraumatic stress disorder: a twin study. Am J Psychiatry 2002; 159: 1675-1681.
43. Sartor CE, Grant JD, Lynskey MT, et al. Common heritable contributions to low-risk trauma, high-risk trauma, posttraumatic stress disorder, and major depression. Arch Gen Psychiatry 2012; 69: 293-299.
44. Logue MW, Baldwin C, Guffanti G, et al. A genome-wide association study of posttraumatic stress disorder identifies the retinoid-related orphan receptor alpha (RORA) gene as a significant risk locus. Mol Psychiatry 2013; 18: 937-942.
45. Xie P, Kranzler HR, Yang C, Zhao H, Farrer LA, Gelertner J,. Genome-wide association study identifies new susceptibility loci for posttraumatic stress disorder. Bio Psychiatry, in press.
46. Cornelis MC, Nugent NR, Amstadter AB, Koenen KC,. Genetics of post-traumatic stress disorder: review and recommendations for genome-wide association studies. Curr Psychiatr Rep 2010; 12: 313-326.
47. Bale TL, Vale WW,. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J Neurosci 2003; 23: 5295-5301. (Pubitemid 36793258)
48. Falush D, Stephens M, Pritchard JK,. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003; 164: 1567-1587. (Pubitemid 37102217)
49. Pritchard JK, Stephens M, Donnelly P,. Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945-959. (Pubitemid 30397141)
50. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D,. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909. (Pubitemid 44141658)
51. Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8: 75-90.
52. Weathers FW, Ruscio AM, Keane TM,. Psychometric properties of nine scoring rules for the Clinician-Administered Posttraumatic Stress Disorder Scale. Psychol Assess 1999; 11: 124-133. (Pubitemid 29279327)
53. Kubany ES, Leisen MB, Kaplan AS, et al. Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: The Traumatic Life Events Questionnaire. Psychol Assess 2000; 12: 210-224.
54. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
55. Muthén LK, Muthén BO,. Mplus User's Guide. 6th ed. Los Angeles, CA: Muthén & Muthén; 1998-2010.
56. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
57. King DW, Leskin GA, King LA, et al. Confirmatory factor analysis of the clinician-administered PTSD scale: evidence for the dimensionality of posttraumatic stress disorder. Psychol Assess 1998; 10: 90-96. (Pubitemid 28292793)
58. Hu L, Bentler PM,. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling 1999; 6: 1-55.
59. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 2005; 62: 617-627. (Pubitemid 40973437)
60. Weiser MJ, Goel N, Sandau US, et al. Androgen regulation of corticotropin-releasing hormone receptor 2 (CRHR2) mRNA expression and receptor binding in the rat brain. Exp Neurol 2008; 214: 62-68.
61. Deussing JM, Breu J, Kuhne C, et al. Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J Neurosci 2010; 30: 9103-9116.